N 
9.62
+2.12%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue, before interest expense
$29.88bn
FY2017FY2026
Net income
$2.27bn
FY2017FY2026
Total assets
$393.32bn
FY2017FY2026
Shareholders' equity
$23.28bn
FY2017FY2026
Income statement
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue, before interest expense | $29.88bn | $28.29bn | $24.95bn | $14.42bn | $8.63bn | $8.88bn | $10.91bn | $10.84bn | $11.12bn | $9.97bn |
| Research and development | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $3.39bn | $2.96bn | $1.72bn | $1.17bn | $1.42bn | $1.45bn | $1.56bn | −$236.7m | $2.06bn | $2.03bn |
| Net income | $2.27bn | $2.14bn | $1.04bn | $582.5m | $897.8m | $961.3m | $1.36bn | −$630.6m | $1.38bn | $1.50bn |
| Diluted earnings per share | 0.76 | 0.71 | 0.34 | 0.19 | 0.29 | 0.30 | 0.43 | -0.19 | 0.41 | 0.43 |
Balance sheet
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $393.32bn | $356.63bn | $346.24bn | $299.93bn | $272.56bn | $266.94bn | $276.25bn | $257.22bn | $254.85bn | $269.04bn |
| Cash and short-term investments | $31.44bn | $34.62bn | $32.37bn | $28.39bn | $91.98bn | $26.15bn | $24.33bn | $20.48bn | $18.58bn | $18.66bn |
| Total liabilities | $369.11bn | $334.14bn | $324.59bn | $279.69bn | $253.89bn | $249.63bn | $259.10bn | $240.39bn | $237.27bn | $251.19bn |
| Debt | $111.01bn | $193.24bn | $190.72bn | $160.89bn | $144.29bn | $143.31bn | $161.60bn | $149.65bn | $143.68bn | $155.92bn |
| Shareholders' equity | $23.28bn | $21.79bn | $21.03bn | $19.77bn | $18.30bn | $16.92bn | $16.66bn | $16.52bn | $17.26bn | $17.52bn |
| Shares outstanding | 3,011m | 3,033m | 3,067m | 3,138m | 3,111m | 3,163m | 3,155m | 3,236m | 3,341m | 3,500m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue, before interest expense | $8.15bn | $8.53bn | $7.37bn | $6.99bn | $6.98bn | $6.16bn | $7.25bn | $7.50bn |
| Operating income | $1.33bn | $676.0m | $849.0m | $857.9m | $1.01bn | $613.7m | $868.2m | $835.1m |
| Net income | $913.9m | $464.2m | $574.8m | $578.1m | $656.5m | $451.9m | $636.9m | $617.7m |
| Diluted earnings per share | 0.30 | 0.15 | 0.19 | 0.19 | 0.22 | 0.15 | 0.21 | 0.20 |
| Total assets | $428.34bn | $393.32bn | $388.85bn | $379.01bn | $364.78bn | $356.63bn | $380.03bn | $360.75bn |
| Cash and short-term investments | $219.72bn | $31.44bn | $285.52bn | $217.55bn | $271.52bn | $34.62bn | $183.36bn | $36.35bn |
| Debt | $220.87bn | $111.01bn | $198.56bn | $196.24bn | $192.30bn | $193.24bn | $199.52bn | $200.12bn |
| Shareholders' equity | $24.07bn | $23.28bn | $22.93bn | $21.88bn | $21.82bn | $21.79bn | $22.41bn | $20.72bn |
Financial ratios
Data as of 24 Sept 2026
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Operating margin | 11.3% | 10.5% | 6.9% | 8.1% | 16.5% | 16.3% | — | — |
| Net margin | 7.6% | 7.6% | 4.2% | 4.0% | 10.4% | 10.8% | — | — |
| Return on equity | 9.8% | 9.8% | 5.0% | 2.9% | 4.9% | 5.7% | — | — |
| Return on assets | 0.6% | 0.6% | 0.3% | 0.2% | 0.3% | 0.4% | — | — |
| Revenue growth | 5.6% | 13.4% | 73.0% | 67.1% | -2.9% | -18.6% | — | — |
| Earnings growth | 6.3% | 105.4% | 78.8% | -35.1% | -6.6% | -29.4% | — | — |
| Current ratio | 1.43x | 0.21x | 0.21x | 0.20x | 0.71x | 0.20x | — | — |
| Debt to equity | 4.77x | 8.98x | 9.18x | 8.14x | 7.99x | 8.57x | — | — |
| Equity ratio | 5.9% | 6.1% | 6.1% | 6.6% | 6.7% | 6.3% | — | — |
| Interest coverage | 0.21x | 0.17x | 0.11x | 0.16x | 0.98x | 1.07x | — | — |
| R&D as a share of sales | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Buybacks as a share of market value | 0.7% | 1.1% | 2.3% | -0.9% | 1.6% | -0.2% | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 27.5% | 27.5% | 11.8% |
| Operating income | 42.7% | 18.5% | 12.6% |
| Net income | 57.4% | 18.8% | 10.7% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 10.9% | 9.5% | 10.5% | 11.1% |
| Net margin | 7.6% | 6.2% | 6.9% | 7.4% |
Valuation history
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 13.0 | 11.9 | 17.1 | 24.3 | 13.0 | 14.3 | 12.3 | -26.5 | 9.0 | 13.5 |
| Price to sales | 1.0 | 0.9 | 0.7 | 1.0 | 1.4 | 1.5 | 1.5 | 1.5 | 1.1 | 2.0 |
Market value over time
31 Oct 2016 to 23 Sept 2026, in USD
$18.25bn$29.63bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 44% | 30% | 24% | -19% | -15% | -0% | 39% | -38% | -5% | 13% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.